United States Malaria Vaccines Market Industry Outlook & Growth Forecast | Major Players 2025 - GlaxoSmithKline Biologicals, Swiss Serum Institute, WRAIR

"Global Malaria Vaccines market is expected to grow at a CAGR Of 31.85% during the forecast period 2024-2031." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/malaria-vaccines-market?sp

United States: Recent Malaria Vaccine Developments

✅ In September 2025, Pfizer launched its next-generation malaria vaccine candidate in Maryland, targeting Plasmodium falciparum.The vaccine demonstrated improved efficacy and longer-lasting immunity in Phase 3 clinical trials.

✅ In August 2025, Sanofi invested $50 million to expand malaria vaccine R&D and manufacturing facilities in North Carolina.The initiative focuses on advanced mRNA-based vaccines.Commercial rollout is expected by Q1 2026.

✅ In July 2025, Moderna introduced a booster malaria vaccine in Massachusetts with enhanced immune response and cross-strain protection.The candidate is entering global Phase 3 trials targeting high-risk populations.

✅ In June 2025, GSK completed clinical validation of a recombinant protein-based malaria vaccine in Pennsylvania.The vaccine showed strong efficacy in children and adults in endemic regions and is preparing for regulatory submission.

Japan: Recent Malaria Vaccine Developments

✅ In September 2025, Takeda Pharmaceuticals launched a next-generation malaria vaccine development program in Tokyo.The initiative focuses on recombinant and mRNA-based platforms to support global immunization efforts.

✅ In August 2025, Daiichi Sankyo invested in malaria vaccine research and local production facilities in Osaka.The goal is to develop vaccines targeting multiple Plasmodium strains.Pilot studies are underway, with global collaboration.

✅ In July 2025, Kitasato University introduced a recombinant malaria vaccine candidate in Kyoto for preclinical studies.The vaccine aims to elicit robust immunity against multiple Plasmodium species and support regional disease control.

✅ In June 2025, Shionogi & Co. completed preclinical testing of a novel malaria vaccine platform in Fukuoka.The platform leverages protein subunit and adjuvant technology to enhance immunogenicity and durability.Nationwide clinical trials are planned for late 2025.

Malaria Vaccines Market: Drivers

The malaria vaccines market is experiencing significant growth as global healthcare organizations and governments intensify efforts to prevent and control malaria, particularly in regions with high disease prevalence. Rising adoption is driven by the urgent need to reduce morbidity and mortality associated with Plasmodium infections, especially among children and vulnerable populations. Additionally, increasing investments in vaccine research, development, and public immunization programs are fueling market demand. Expansion of healthcare infrastructure, awareness campaigns, and international collaborations for malaria prevention further support market growth. The push for sustainable disease control and alignment with global health initiatives is also contributing to rising adoption.

Technological advancements are significantly enhancing the malaria vaccines market. Innovations in recombinant vaccine technology, mRNA platforms, and adjuvant formulations improve immunogenicity, safety, and efficacy. Development of multi-stage and combination vaccines targets different parasite life cycle stages to provide broader protection. Advances in cold-chain logistics, scalable manufacturing processes, and formulation stability ensure reliable distribution and accessibility in endemic regions. Continuous research in genetic engineering, immunology, and clinical trial optimization supports next-generation vaccine development. With ongoing innovation and global public health initiatives, the malaria vaccines market is poised for sustained growth.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/malaria-vaccines-market?sp

Malaria Vaccines Market: Major Players

GlaxoSmithKline Biologicals (GSK), the Swiss Serum Institute, WRAIR, Sanaria, BioNTech, Nobelpharma, CellFree Sciences, Sumaya Biotech, VLP Therapeutics LLC, Bharat Biotech, Serum Institute of India, Novavax, Kenya medical research institute.

Segment Covered in the Malaria Vaccines Market:

➥ By Type of Infectious Agents: Plasmodium Falciparum, Species of Anopheles, P. vivax, P. malariae, Others
➥ By Type of Vaccines: Erythrocytic, Pre-Erythrocytic, Multi Antigen, Others
➥ By End User: Hospitals, Specialty Clinics, Retail Pharmacy, Others

Research Process:

Both primary and secondary data sources have been used in the Malaria Vaccines Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Malaria Vaccines Market Research Industry:

➠ Who leads the Malaria Vaccines industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Malaria Vaccines market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Malaria Vaccines market growth?
➠ What are the dominant sales and distribution strategies in the Malaria Vaccines industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=malaria-vaccines-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.